The following field have been updated with a correction: e.4: medwatch report #2400010000-2023-8029.The initial reporter notified the fda on: 01-dec-2023.After further evaluation of the complaint, it has been determined that, the previous medwatch report # provided on e.4: "the initial reporter notified the fda on dd-mmm-yyyy.Medwatch report # 2400010000-2023-8026 and 2400010000-2023-8025" was sent in error, the correct report # is 2400010000-2023-8029.The exact day was unknown, so 1st day of the month has been used.H.6.Investigation summary: material #: 368650, lot/batch #: 3223399.Bd had not received samples or photos for investigation.Therefore, 20 retention samples from bd inventory were evaluated by functional testing, each having their eclipse shield activated, and no issues were observed relating to defective locking mechanism as all samples met specifications.Based on a review of the device history record for the incident lot, all product specifications and requirements for lot release were met.There were no related quality issues during manufacturing of the product.This complaint is unable to be confirmed for the indicated failure mode defective locking mechanism.Bd was not able to identify a root cause for the indicated failure mode.
|